Drugs / Sanguisorba officinalis L.
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02663492 Comparator | Aug 2014 → Jan 2016 | non-small cell lung carcinoma | Tongji University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sanguisorba officinalis L. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02663492 ↗ |
| Known as | Diyu Shengbai Pian | “Sanguisorba officinalis L., a Leukogenic medication, named Diyu Shengbai Pian (Chengdu Diao Tianfu Pharmaceutical Group Co., Ltd., China) will be taken 0.4g each time by 3...” NCT02663492 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Sanguisorba officinalis L., named Diyu Shengbai Pian (a Traditional Chinese Medicine) 3 times per day.” NCT02663492 ↗ |